Atorvastatin Is a Promising Partner for Antimalarial Drugs in Treatment of Plasmodium falciparum Malaria

Atorvastatin (AVA) is a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. AVA exposure resulted in the reduced in vitro growth of 22 Plasmodium falciparum strains, with the 50% inhibitory concentrations (IC(50)s) ranging from 2.5 μM to 10.8 μM. A significant positive correlation was found b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Parquet, Véronique, Briolant, Sébastien, Torrentino-Madamet, Marylin, Henry, Maud, Almeras, Lionel, Amalvict, Rémy, Baret, Eric, Fusaï, Thierry, Rogier, Christophe, Pradines, Bruno
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2009
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2687225/
https://ncbi.nlm.nih.gov/pubmed/19307369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01462-08
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados